Clinical Trial Update: Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia [NA]

View source ↗

Summary

A clinical trial evaluating autologous hematopoietic cell transplantation for core-binding factor acute myeloid leukemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Autologous hematopoietic cell transplantation

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia, Myeloid | NA | Status: COMPLETED